Heparin Anticoagulant Market USD 10.8 Billion by 2020, Published by iHealthcareAnalyst, Inc.
Maryland Heights, MO, October 27, 2016 --(PR.com)-- The global heparin anticoagulant market is estimated to reach USD 10.8 Billion in 2020, growing at a CAGR of 4.4% from 2016 to 2020, according to a market research report Heparin Anticoagulant Market 2013-2020, published by iHealthcareAnalyst, Inc.
Visit the Heparin Anticoagulant Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/heparin-anticoagulant-market/
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. It is used to treat and prevent deep vein thrombosis and pulmonary embolism (collectively known as venous thromboembolism) and is also used as part of the treatment of myocardial infarction and unstable angina. Heparin is used on the inside surfaces of various devices such as test tubes and kidney dialysis machines.
The global heparin anticoagulant market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020). The global heparin anticoagulant market segmentation is based on products (unfractionated heparin, low molecular weight heparin, ultra-low molecular weight heparin). The global heparin anticoagulant market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Product Type
1.1 Unfractionated Heparin
1.2 Low Molecular Weight Heparin
1.3 Ultra-low Molecular Weight Heparin
2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World
3. Company Profiles
3.1 Dr. Reddy’s Laboratories Ltd.
3.2 Fresenius Kabi AG
3.3 LEO Pharma A/S
3.4 Mylan N.V.
3.5 Pfizer, Inc.
3.6 Sanofi S.A.
3.7 Syntex S.A.
3.8 Teva Pharmaceuticals Industries Ltd.
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: https://www.ihealthcareanalyst.com
Visit the Heparin Anticoagulant Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/heparin-anticoagulant-market/
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. It is used to treat and prevent deep vein thrombosis and pulmonary embolism (collectively known as venous thromboembolism) and is also used as part of the treatment of myocardial infarction and unstable angina. Heparin is used on the inside surfaces of various devices such as test tubes and kidney dialysis machines.
The global heparin anticoagulant market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020). The global heparin anticoagulant market segmentation is based on products (unfractionated heparin, low molecular weight heparin, ultra-low molecular weight heparin). The global heparin anticoagulant market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Product Type
1.1 Unfractionated Heparin
1.2 Low Molecular Weight Heparin
1.3 Ultra-low Molecular Weight Heparin
2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World
3. Company Profiles
3.1 Dr. Reddy’s Laboratories Ltd.
3.2 Fresenius Kabi AG
3.3 LEO Pharma A/S
3.4 Mylan N.V.
3.5 Pfizer, Inc.
3.6 Sanofi S.A.
3.7 Syntex S.A.
3.8 Teva Pharmaceuticals Industries Ltd.
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: https://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Contact
Categories